These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Selexipag for the Treatment of Pulmonary Arterial Hypertension. Sitbon O; Channick R; Chin KM; Frey A; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; Preiss R; Rubin LJ; Di Scala L; Tapson V; Adzerikho I; Liu J; Moiseeva O; Zeng X; Simonneau G; McLaughlin VV; N Engl J Med; 2015 Dec; 373(26):2522-33. PubMed ID: 26699168 [TBL] [Abstract][Full Text] [Related]
9. Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study. Coghlan JG; Channick R; Chin K; Di Scala L; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin V; Preiss R; Rubin LJ; Simonneau G; Sitbon O; Tapson VF; Gaine S Am J Cardiovasc Drugs; 2018 Feb; 18(1):37-47. PubMed ID: 29307087 [TBL] [Abstract][Full Text] [Related]
10. [Experience with Selexipag to Treat Pulmonary Arterial Hypertension]. Karelkina EV; Goncharova NS; Simakova MA; Moiseeva OM Kardiologiia; 2020 Mar; 60(4):36-42. PubMed ID: 32394855 [TBL] [Abstract][Full Text] [Related]
11. Selexipag for the treatment of pulmonary arterial hypertension. Genecand L; Wacker J; Beghetti M; Lador F Expert Rev Respir Med; 2021 May; 15(5):583-595. PubMed ID: 33382345 [TBL] [Abstract][Full Text] [Related]
12. Risk assessment in pulmonary arterial hypertension: Insights from the GRIPHON study. Sitbon O; Chin KM; Channick RN; Benza RL; Di Scala L; Gaine S; Ghofrani HA; Lang IM; McLaughlin VV; Preiss R; Rubin LJ; Simonneau G; Tapson VF; Galiè N; Hoeper MM J Heart Lung Transplant; 2020 Apr; 39(4):300-309. PubMed ID: 32061506 [TBL] [Abstract][Full Text] [Related]
13. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension. Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349 [TBL] [Abstract][Full Text] [Related]
14. Selexipag for the treatment of pulmonary arterial hypertension. Skoro-Sajer N; Lang IM Expert Opin Pharmacother; 2014 Feb; 15(3):429-36. PubMed ID: 24392948 [TBL] [Abstract][Full Text] [Related]
15. An evaluation of selexipag for the treatment of pulmonary hypertension. Panagiotidou E; Boutou A; Pitsiou G Expert Opin Pharmacother; 2021 Jan; 22(1):29-36. PubMed ID: 32867545 [TBL] [Abstract][Full Text] [Related]
16. A Special Focus on Selexipag - Treatment of Pulmonary Arterial Hypertension. Sorensen LM; Wehland M; Kruger M; Simonsen U; Nassef MZ; Infanger M; Grimm D Curr Pharm Des; 2017; 23(34):5191-5199. PubMed ID: 28891448 [TBL] [Abstract][Full Text] [Related]
17. Selexipag in Pulmonary Arterial Hypertension: Most Updated Evidence From Recent Preclinical and Clinical Studies. Ghosh RK; Ball S; Das A; Bandyopadhyay D; Mondal S; Saha D; Gupta A J Clin Pharmacol; 2017 May; 57(5):547-557. PubMed ID: 27670133 [TBL] [Abstract][Full Text] [Related]